For DAT binding, those patients in the lowest quartile for depression compared to the highest quartile had significantly higher binding in the total striatum (3.3±0.7 and 3.7±0.2 respectively, p = 0.01 by Wilcoxon Two Sample Test). This evidence concerns the gene SLC6A3 and depressive symptom measurement.